Altitude Acquisition Corp.
ALTUU
NASDAQ Capital Market10.10
USD
-0.16
- -
CIK
0001822366
ISIN
US02156Y2028
CUSIP
02156Y202
Return %
Stock
S&P500
1Y
0.90
18.21
3Y
-6.48
64.38
5Y
-1.08
72.43
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Gary Teplis
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 400 Perimeter Center Terrace Atlanta GA United States of America 30346
- IPO Date
- Dec 9, 2020
- CIK
- 0001822366
- Website
- altitudeac.com
- Similar Companies
- Business
- Altitude Acquisition Corp. (ALTUU) is a blank check company, or special purpose acquisition company (SPAC), formed to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, with a focus on travel, travel technology and travel-related businesses including booking engines, revenue management services, travel management companies, alternative accommodations and mobile travel solutions targeting both business-to-business and business-to-consumer markets. Incorporated in 2020 and headquartered in Atlanta, Georgia, the company operates as a subsidiary of Altitude Acquisition Holdco LLC and conducts no significant operations or generates revenues prior to completing an initial business combination. Its securities trade on Nasdaq under the tickers ALTU for Class A ordinary shares and ALTUU for units. Recent major developments include multiple deadline extensions for its initial business combination from late 2023 through March 2024 to pursue deals such as a terminated agreement with Picard Medical Inc. and SynCardia Systems valued at a $480 million enterprise value in April 2023, followed by a February 2024 business combination agreement with Vesicor Therapeutics Inc., an early-stage biopharmaceutical developer of microvesicle-based therapeutics, at a $70 million valuation; both transactions failed to close. In March 2024, Altitude announced the liquidation of its trust account, redemption of all outstanding Class A shares, delisting from Nasdaq and termination under Section 12(g), with SEC filings in April 2024 confirming deregistration and removal from listing.
Altitude Acquisition Corp. Announces Liquidation of Trust Account
Altitude Acquisition Corp. Announces Extension of Deadline to Complete Initial Business Combination
Altitude Acquisition Corp. Announces Extension of Deadline to Complete Initial Business Combination
Altitude Acquisition Corp. Announces Extension of Deadline to Complete Initial Business Combination
Altitude Acquisition Corp. Announces Extension of Deadline to Complete Initial Business Combination
Altitude Acquisition Corp. Announces Extension of Deadline to Complete Initial Business Combination
Altitude Acquisition Corp. Announces the Separate Trading of its Common Stock and Warrants, Commencing January 29, 2021